Postdoc position Long-COVID/ auto antibodies (m/f/d)
Nephropathologie
38.5 Stunden
auf 24 Monate befristet
ab 01.06.2026
Eingruppierung gemäß
TV-L
Bewerbungsfrist 30.04.2026
Universitätsklinikum Erlangen
Nephropatholgische Abteilung
Prof. Felix B. Engel
Krankenhausstraße 8-10
91054 Erlangen
Nephropatholgische Abteilung
Prof. Felix B. Engel
Krankenhausstraße 8-10
91054 Erlangen
Ansprechperson bei Fragen
Prof. Felix B. Engel
Telefon: -35659
Prof. Felix B. Engel
Telefon: -35659
Postdoc position Long-COVID/ auto antibodies (m/f/d)
Veröffentlicht seit: 29.01.2026Job-Nr.: 12162
Prof. Felix B. Engel
Telefon: -35659
Telefon: -35659
Universitätsklinikum Erlangen
Nephropatholgische Abteilung
Prof. Felix B. Engel
Krankenhausstraße 8-10
91054 Erlangen
Nephropatholgische Abteilung
Prof. Felix B. Engel
Krankenhausstraße 8-10
91054 Erlangen
Postdoc position Long-COVID/ auto antibodies (m/f/d)
Veröffentlicht seit: 29.01.2026
Job-Nr.: 12162
Prof. Felix B. Engel
Telefon: -35659
Veröffentlicht seit: 29.01.2026
Job-Nr.: 12162
Universitätsklinikum Erlangen
Nephropatholgische Abteilung
Prof. Felix B. Engel
Krankenhausstraße 8-10
91054 Erlangen
Ansprechperson bei FragenNephropatholgische Abteilung
Prof. Felix B. Engel
Krankenhausstraße 8-10
91054 Erlangen
Prof. Felix B. Engel
Telefon: -35659
Klingt spannend?
Das sind wir:
Outstanding patient care, award-winning research and teaching and cutting-edge medicine and diagnosis is what defines us, Universitätsklinikum Erlangen. With over 10,000 highly qualified members of staff, we are one of the largest employers in Middle Franconia, and we are still growing steadily. Thanks to the scientific expertise and dedication of our staff, we can offer our patients individual and pioneering treatment options. This is how we can guarantee medical progress. We are confident that you will find a job with us that fits you perfectly, and benefits others as well.
Your tasks:
| Background of the project: This position is integrated in the research consortium PERCOLATE. The overall aim of PERCOLATE is to establish a rapid and easy-to-use diagnostic test panel, based on detection of functional autoantibodies targeting G-protein coupled receptors (GPCR-fAAb) in combination with GPCR-fAAb mediated ischaemia-reperfusion parameters, accompanied by profiling of immune cells and viral reactivation in patients with Long-COVID (LC) and Post-Vaccination Syndrome (Post-VAC) for a personalized patients’ stratification and care. Your task will be to develop alternative methods to the assay by Wallukat et al., in which primary rat cardiomyocytes were used, to detect the functional active GPCR-AAbs from patients’ sera (~300 samples). Examples of assays are genetically encoded reporter lines or visualization of receptor internalization. The cell system has to be a human system like hiPSC-derived cardiomyocytes but could also be a human standard cell line. In addition, we expect the development of a research project aiming at a better mechanistic understanding of the disease with the focus of the role of autoantibodies (or alternatively a focus that the applicant has experience in; e.g., immune cells). |
Comments:
- Funding: The project is funded by the Ministry of Health. Salary: E13, 100% for 2 years with possible extension (funded until 31.12.2028).
- The position can also be done part-time in principle
- The starting date is as soon as possible
- Please provide: CV, Letter of Motivation, Letters of Recommendation, Short proposal regarding your approach to detect functional autoantibodies and a „mechanistic project“(max. 2 pages, not generated by AI).